Why is Stemetil discontinued? The Recall of a Common Medication
•
3 min read
In a significant safety measure, batches of Stemetil 5mg/5ml syrup were recalled in 2022 by manufacturer Sanofi due to the presence of a probable human carcinogen, explaining the discontinuation of this specific formulation. This action was triggered after laboratory tests identified levels of N-nitrosomethylphenylamine (NMPA) above the acceptable safety limit.
